SCHEMBL7114420

SCHEMBL7114420

CC(=O)OC[C@H]1O[C@@H](O)[C@H](OC(=O)C(C)(C)C)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.46
▸ LMNA P02545 2/20 0.43
▸ NT5E P21589 1/20 0.43
▸ KMT2A Q03164 1/20 0.42
▸ TNF P01375 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ TACR2 P21452 2/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ PTPN6 P29350 1/20 0.37
▸ CDC25A P30304 1/20 0.37
▸ CDC25B P30305 1/20 0.37
▸ PTPN11 Q06124 1/20 0.37
▸ SSTR1 P30872 1/20 0.37
▸ SSTR2 P30874 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7178488 1.00 TSHR (0.46) TSHRLMNANT5EKMT2ATNF
SCHEMBL5160104 0.89 NT5E (0.53) NT5ETACR2PTPN2PTPN1PTPN6
SCHEMBL5160114 0.89 NT5E (0.53) NT5ETACR2PTPN2PTPN1PTPN6
SCHEMBL20287904 0.89 TSHR (0.50) TSHRLMNANT5EKMT2ATNF
SCHEMBL30039523 0.89 TSHR (0.50) TSHRLMNANT5EKMT2ATNF
SCHEMBL20870237 0.89 TSHR (0.50) TSHRLMNANT5EKMT2ATNF
SCHEMBL13380996 0.89 TSHR (0.50) TSHRLMNANT5EKMT2ATNF
SCHEMBL3136372 0.89 TSHR (0.50) TSHRLMNANT5EKMT2ATNF
SCHEMBL21219187 0.88 TSHR (0.59) TSHRLMNAKMT2ATNFALDH1A1
SCHEMBL17502004 0.88 TSHR (0.59) TSHRLMNAKMT2ATNFALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232452-A1 Linkers for synthesis of oligosaccharides on solid supports SEEBERGER PETER H (US) 2003-12-18 — — US disclosed
US-6579725-B1 Compound of given formula; stable to reaction conditions but can also be cleaved; can use to attach building blocks useful in assembly of libraries of other small molecules MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2003-06-17 — — US disclosed
WO-2000052018-A9 LINKERS FOR SYNTHESIS OF OLIGOSACCHARIDES ON SOLID SUPPORTS MASSACHUSETTS INST TECHNOLOGY (US) 2002-06-27 — — WO disclosed
EP-1175427-A2 LINKERS FOR SYNTHESIS OF OLIGOSACCHARIDES ON SOLID SUPPORTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-01-30 — — EP disclosed
WO-2000052018-A2 LINKERS FOR SYNTHESIS OF OLIGOSACCHARIDES ON SOLID SUPPORTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2000-09-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232452-A1 Linkers for synthesis of oligosaccharides on solid supports ILK, OSTC, SI TSHR 4568/4885LMNA 1683/4885NT5E 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback